ATE161967T1 - Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren - Google Patents

Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren

Info

Publication number
ATE161967T1
ATE161967T1 AT92912244T AT92912244T ATE161967T1 AT E161967 T1 ATE161967 T1 AT E161967T1 AT 92912244 T AT92912244 T AT 92912244T AT 92912244 T AT92912244 T AT 92912244T AT E161967 T1 ATE161967 T1 AT E161967T1
Authority
AT
Austria
Prior art keywords
virus
plasma
plasma samples
cells
respiratory virus
Prior art date
Application number
AT92912244T
Other languages
English (en)
Inventor
George R Siber
Jeanne Leszczynski
Original Assignee
Massachusetts Health Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Health Res filed Critical Massachusetts Health Res
Application granted granted Critical
Publication of ATE161967T1 publication Critical patent/ATE161967T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT92912244T 1991-04-22 1992-04-10 Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren ATE161967T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68843591A 1991-04-22 1991-04-22

Publications (1)

Publication Number Publication Date
ATE161967T1 true ATE161967T1 (de) 1998-01-15

Family

ID=24764406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912244T ATE161967T1 (de) 1991-04-22 1992-04-10 Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren

Country Status (13)

Country Link
US (2) US5412077A (de)
EP (1) EP0581882B1 (de)
JP (1) JPH06509866A (de)
AT (1) ATE161967T1 (de)
AU (2) AU668092B2 (de)
CA (1) CA2108259C (de)
DE (1) DE69223955T2 (de)
DK (1) DK0581882T3 (de)
ES (1) ES2113428T3 (de)
FI (1) FI110723B (de)
GR (1) GR3026393T3 (de)
NO (1) NO933697L (de)
WO (1) WO1992018652A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018652A1 (en) * 1991-04-22 1992-10-29 Massachusetts Health Research Institute, Inc. Process of screening plasma samples for effective antibody titers against respiratory viruses
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
EP2305303A3 (de) 1997-10-20 2013-11-13 Sanofi Pasteur Biologics Co. Immunisierung gegen Clostridium difficile-Erkrankung
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
EP2289550A3 (de) * 2000-01-27 2012-02-15 MedImmune, LLC Neutralisierende Antikörper mit ultrahoher Affinität
DK1259547T3 (da) 2000-03-01 2012-10-15 Medimmune Inc Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US20050153382A1 (en) * 2002-06-06 2005-07-14 Chengdu Kuachang Science And Technology Co., Ltd. Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
WO2006050166A2 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
TWI815599B (zh) 2011-04-22 2023-09-11 美商惠氏有限責任公司 與難養芽胞梭菌（Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ）之突變毒素有關之組成物及彼之方法
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2021255690A2 (en) 2020-06-19 2021-12-23 Pfizer Inc. Immunogenic compositions against clostridioides (clostridium) difficile and methods thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315073A (en) * 1979-10-26 1982-02-09 Cutter Laboratories, Inc. Titration of serum influenza antibody using plaque reduction neutralization test
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
US4665379A (en) * 1984-05-10 1987-05-12 Anes Electronics, Inc. Vehicle security system
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
WO1992018652A1 (en) * 1991-04-22 1992-10-29 Massachusetts Health Research Institute, Inc. Process of screening plasma samples for effective antibody titers against respiratory viruses

Also Published As

Publication number Publication date
DK0581882T3 (da) 1998-09-07
US5412077A (en) 1995-05-02
US5582827A (en) 1996-12-10
DE69223955D1 (de) 1998-02-12
AU668092B2 (en) 1996-04-26
EP0581882A4 (en) 1994-06-08
DE69223955T2 (de) 1998-08-13
ES2113428T3 (es) 1998-05-01
FI934657L (fi) 1993-10-21
GR3026393T3 (en) 1998-06-30
FI934657A0 (fi) 1993-10-21
NO933697D0 (no) 1993-10-14
JPH06509866A (ja) 1994-11-02
CA2108259A1 (en) 1992-10-23
WO1992018652A1 (en) 1992-10-29
AU6067896A (en) 1996-10-17
EP0581882B1 (de) 1998-01-07
CA2108259C (en) 2003-12-09
AU680170B2 (en) 1997-07-17
EP0581882A1 (de) 1994-02-09
AU1988592A (en) 1992-11-17
FI110723B (fi) 2003-03-14
NO933697L (no) 1993-10-14

Similar Documents

Publication Publication Date Title
ATE161967T1 (de) Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
Oldstone et al. Formation and biologic role of polyoma virus-antibody complexes: a critical role for complement
DANIELS Mechanisms of viral neutralization
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
Dietrich et al. Transmission of Human Immunodeficiency Virus Type 1 by Dry‐Heated Clotting Factor Concentrates 1
ES8405952A1 (es) Un metodo de detectar un anticuerpo antivirus
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
Monath et al. Comparison of methods for removal of nonspecific inhibitors of arbovirus hemagglutination
WO1993025662A3 (en) Replication of hepatitis c virus genome and identification of virus having high infectivity
ES2118129T3 (es) Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos.
Juhl et al. Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data
JPH05184361A (ja) 生物学的に活性なタンパク質の溶液中における低ｐＨでのリン酸トリ−（ｎ−ブチル）の殺ウイルス活性を増強するための使用
ATE160448T1 (de) Nachweis von thrombopenies
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
FI873233A0 (fi) Modifierade virala glykoproteiner.
DK162726C (da) Fremgangsmaade til eliminering af falsk positive resultater ved bestemmelse af atl virus-antistof og reagens dertil
Zhou et al. Development of an immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay for detection of equine and swine IgM antibodies to vesicular stomatitis virus
SU1467513A1 (ru) Способ определени антигенов вирусов
Hoekstra et al. Counter-Immunoelectrophoresis: Rapid Method for Detecting Group-Specific Antigen and Antibodies Associated with Oncogenic Ribonucleic Acid Viruses
DE3202559A1 (de) Verfahren zum nachweis von igm-antikoerpern gegen hepatitis a-virus und reagens zur durchfuehrung von immunoassays
BE890338A (fr) Procede de preparation de solutions de lipoproteines a partir de residus de delipidation des plasmas et serums et utilisations de celles-ci
Juretić et al. Application of single radial immunodiffusion for qualitative comparison of plant virus particles
SU963509A1 (ru) Способ идентификации антител к поверхностному антигену гепатита В
Young et al. A further example of the low frequency antigen Pta
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee